K2M Receives FDA Clearance for BACS® Patient-Specific Module
Go back to K2M Receives FDA Clearance for BACS® Patient-Specific Module| K2M GROUP HOLDINGS (NASDAQ: KTWO) | Delayed: 9.94 +0.01 (0.10%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.93 | 52 Week High | $21.67 | |||
| Open | $9.94 | 52 Week Low | $10.10 | |||
| Day High | $9.94 | P/E | N/A | |||
| Day Low | $9.94 | EPS | $0.00 | |||
| Volume | 185 | |||||
